Carbon disclosure and net-zero commitments are now strategic imperatives for animal health companies. EU CSRD (Corporate Sustainability Reporting Directive) implementation, SEC climate disclosure rules, and California's SB-253 are driving comprehensive Scope 1, 2, and 3 emissions reporting. Zoetis committed to net-zero by 2050 with a 42% reduction by 2030 (validated by SBTi). Boehringer Ingelheim, Merck & Co., and Elanco have similar commitments. Manufacturing decarbonization, supply chain emissions, and biologics cold chain represent the largest carbon footprint sources. Investment in renewable energy, green manufacturing, and supplier engagement programs is accelerating.
This report provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs.
Topics Covered
• Carbon Footprint Analysis Across the Animal Health Industry
• Net-Zero Commitments and SBTi Validation by Company
• Scope 1, 2, 3 Emissions Reporting Maturity
• Manufacturing Decarbonization — Renewable Energy, Process Innovation
• Supply Chain Emissions and Supplier Engagement Programs
• Biologics Cold Chain Carbon Footprint
• Animal Husbandry Methane Reduction — Cattle, Aquaculture
• EU CSRD, SEC Climate, and California SB-253 Compliance
• Carbon Pricing and Internal Carbon Cost Strategies
• Investor Pressure and ESG-Linked Financing
Table of Contents
1. Executive Summary
2. Market Overview
3. Carbon Footprint Analysis
4. Net-Zero Commitments
5. Scope 1, 2, 3 Emissions Reporting
6. Manufacturing Decarbonization
7. Supply Chain Emissions
8. Biologics Cold Chain
9. Methane Reduction Programs
10. Regulatory Compliance — EU, SEC, California
11. Carbon Pricing
12. Investor Pressure
13. Market Challenges and Risks
14. Strategic Conclusions and Recommendations
15. Appendix
List of Tables
Table 1. Animal Health Industry Carbon Footprint by Company
Table 2. Net-Zero Commitments and Targets by Company
Table 3. Scope 1, 2, 3 Emissions by Company 2023-2025
Table 4. Manufacturing Decarbonization Investment
Table 5. Supply Chain Emissions Hot Spots
Table 6. Biologics Cold Chain Carbon Footprint
Table 7. Methane Reduction Pilot Programs
Table 8. Regulatory Compliance Status by Company
Table 9. Carbon Pricing Adoption by Company
Table 10. ESG-Linked Financing Activity 2023-2026
Companies Profiled
Boehringer Ingelheim Animal Health
Ceva Santé Animale
Elanco Animal Health
IDEXX Laboratories
Merck Animal Health
Vetoquinol
Virbac
Zoetis
